Sanofi | SNY - Assets




Sanofi reported 129.76B in Assets for its fiscal quarter ending in June of 2024.

Assets Change Date
AbbVie USD 143.42B 1.48B Sep/2024
Amgen USD 91.84B 956M Dec/2024
AstraZeneca USD 104.04B 887M Dec/2024
Bristol-Myers Squibb USD 92.6B 1.07B Dec/2024
Canopy Growth CAD 1.23B 53.88M Sep/2024
Corcept Therapeutics USD 784.26M 69.7M Sep/2024
Drreddys Laboratories INR 465.96B 50.66B Sep/2024
Eli Lilly USD 75.61B 3.73B Sep/2024
Galapagos EUR 4.14B 36.48M Dec/2024
Genmab DKK 45.81B 6.15B Dec/2024
GlaxoSmithKline GBP 59.46B 1.41B Dec/2024
Glaxosmithkline GBP 58.05B 17M Sep/2024
Indivior 1.46B 71M Sep/2024
J&J USD 178.29B 2.8B Sep/2024
Merck USD 117.53B 4.9B Sep/2024
Novartis USD 102.25B 1.28B Dec/2024
Novartis USD 103.52B 6.02B Sep/2024
Pacira USD 1.52B 125.13M Sep/2024
Perrigo USD 11.2B 805.9M Sep/2024
Pfizer USD 219.48B 3.28B Sep/2024
Prestige Brands USD 3.33B 12.61M Dec/2024
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 129.76B 3.29B Jun/2024
Sanofi 129.76B 3.29B Jun/2024
Supernus Pharmaceuticals USD 1.34B 26.87M Sep/2024
UCB EUR 15.63B 90M Jun/2024
Zoetis USD 14.24B 120M Dec/2024